Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

23.75
Delayed Data
As of Jan 20
 +0.05 / +0.21%
Today’s Change
4.37
Today|||52-Week Range
23.81
+90.92%
Year-to-Date
Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
Jan 20 / Zacks.com - Paid Partner Content
Becton, Dickinson Commercially Launches Precise WTA Kits
Jan 18 / Zacks.com - Paid Partner Content
Abbvie (ABBV) Imbruvica Approved in Lymphoma Indication
Jan 20 / Zacks.com - Paid Partner Content
Jazz Begins Phase III Study for Label Expansion of Defitelio
Jan 18 / Zacks.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
Jan 18 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for ARIAD Pharmaceuticals (ARIA)?
Jan 20 / Zacks.com - Paid Partner Content
Baxter (BAX): Sluggish Macro Environment Mars Prospects
Jan 18 / Zacks.com - Paid Partner Content
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
These 3 Stocks Have Doubled Since Election Day
Jan 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close23.70
Today’s open23.73
Day’s range23.72 - 23.80
Volume11,638,351
Average volume (3 months)9,593,439
Market cap$4.6B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+97.20%
Earnings growth (next 5 years)-25.54%
Revenue growth (last year)+12.70%
P/E ratioNM
Price/Sales9.93
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+0.02+0.02%
NBIXNeurocrine Bioscienc...-0.35-0.84%
XONIntrexon Corp-0.20-0.85%
BLUEbluebird bio Inc-1.05-1.58%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$118.8M
Annual profit (last year)-$231.2M
Net profit margin-194.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paris Panayiotopoulos
Chief Financial Officer, Treasurer &
Executive VP
Manmeet Singh Soni
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs